Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

China · Delayed Price · Currency is CNY

2.920

-0.020 (-0.68%)

Jun 2, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Drugs and Devices	7.13B	7.79B	7.96B	12.21B	20.95B
Drugs and Devices Growth	-8.48%	-2.13%	-34.84%	-41.72%	-22.76%
Sales of Mobile Medical Software and Services	45.75M	68.41M	52.34M	77.20M	86.88M
Sales of Mobile Medical Software and Services Growth	-33.13%	30.70%	-32.21%	-11.13%	15.48%
Lease	28.56M	24.13M	25.42M	22.72M	19.14M
Lease Growth	18.35%	-5.06%	11.89%	18.72%	-36.27%
Sales of Other Products	95.10M	86.82M	-	-	-
Sales of Other Products Growth	9.54%	-	-	-	-
Total	7.30B	7.97B	8.03B	12.31B	21.06B
Total Growth	-8.42%	-0.84%	-34.74%	-41.54%	-22.67%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	7.30B	7.97B	8.03B	12.31B	21.06B
China Growth	-8.42%	-0.84%	-34.74%	-41.54%	-22.67%
Total	7.30B	7.97B	8.03B	12.31B	21.06B
Total Growth	-8.42%	-0.84%	-34.74%	-41.54%	-22.67%

Source: S&P Global Market Intelligence.